Icatibant Acetate - NDC Database

11 records found

Page:1

0093-3066 Jul 15, 2019
Icatibant 10 mg/ml Subcutaneous Injection, Solution by Teva Pharmaceuticals USA, Inc.

24201-207 Mar 09, 2020
Icatibant 30 mg/3ml Subcutaneous Injection, Solution by Leucadia Pharmaceuticals

55150-351 Aug 14, 2023
Icatibant 30 mg/3ml Subcutaneous Injection, Solution by Eugia Us LLC

60505-6214 Apr 15, 2021
Icatibant 30 mg/3ml Subcutaneous Injection, Solution by Apotex Corp.

62332-654 Jun 14, 2024
Icatibant 30 mg/3ml Subcutaneous Injection by Alembic Pharmaceuticals Inc.

63323-574 Nov 15, 2020
Icatibant 10 mg/ml Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC

68462-828 May 21, 2021
Icatibant 30 mg/3ml Subcutaneous Injection, Solution by Glenmark Pharmaceuticals Inc., USA

69097-664 Jul 13, 2020
Icatibant 30 mg/3ml Subcutaneous Injection by Cipla USA Inc.

70709-013 Jun 03, 2021
Icatibant 30 mg/3ml Subcutaneous Injection by Cycle Pharmaceuticals Ltd-uk

71225-114 Jan 28, 2021
Icatibant 30 mg/3ml Subcutaneous Injection by Slayback Pharma LLC

72162-2106 Apr 15, 2021
Icatibant 30 mg/3ml Subcutaneous Injection, Solution by Bryant Ranch Prepack

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.